Proton Therapy for Chordomas and/or Chondrosarcomas

Completed

• Conditions: Chondrosarcomas; Chordomas

• Registration Number: NCT00797602
• Lead Sponsor: University of Florida

Brief Summary

The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.

Detailed Description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up.

Study Timeline

• Study Start: 2007-01
• Study First Submitted: 2008-11-24
• Study First Submitted QC: 2008-11-24
• Study First Posted: 2008-11-25
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-10
• Last Update Posted: 2017-08-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 189

Inclusion Criteria

• Histologically proven chordoma or chondrosarcoma.
• Sites: base of skull and/or spine.
• Age 18 years or older.

Exclusion Criteria

• Previous radiation to the head and neck or brain.
• Evidence of metastatic disease.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Collect and analyze outcome data on tumor control.	When each patient has been followed for a minimum of 12 month and then again after 24 months to a maximum of 10 years.

Secondary Outcome Measures

Name	Time	Method
Collect and analyze data on normal tissue morbidity.	When each patient has been followed for a minimum of 12 months and then again after 24 months to a maximum of 10 years.	Specifically analyzing pituitary, visual and hearing function.

Trial Locations

Locations (1)

University of Florida Proton Therapy Institute; 🇺🇸 Jacksonville, Florida, United States